BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24935252)

  • 1. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
    Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
    Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
    Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
    Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation.
    Louisse J; Verwei M; Woutersen RA; Blaauboer BJ; Rietjens IM
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):11-27. PubMed ID: 22114915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
    Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
    Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
    Louisse J; Gönen S; Rietjens IM; Verwei M
    Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
    Adler S; Pellizzer C; Hareng L; Hartung T; Bremer S
    Toxicol In Vitro; 2008 Feb; 22(1):200-11. PubMed ID: 17961973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure.
    Colleoni S; Galli C; Gaspar JA; Meganathan K; Jagtap S; Hescheler J; Sachinidis A; Lazzari G
    Toxicol Sci; 2011 Dec; 124(2):370-7. PubMed ID: 21934132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling.
    Verwei M; van Burgsteden JA; Krul CA; van de Sandt JJ; Freidig AP
    Toxicol Lett; 2006 Aug; 165(1):79-87. PubMed ID: 16517103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
    Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells.
    Adler S; Lindqvist J; Uddenberg K; Hyllner J; Strehl R
    Altern Lab Anim; 2008 May; 36(2):129-40. PubMed ID: 18522481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds.
    de Jong E; Louisse J; Verwei M; Blaauboer BJ; van de Sandt JJ; Woutersen RA; Rietjens IM; Piersma AH
    Toxicol Sci; 2009 Jul; 110(1):117-24. PubMed ID: 19401353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A statistical approach towards the derivation of predictive gene sets for potency ranking of chemicals in the mouse embryonic stem cell test.
    Schulpen SH; Pennings JL; Tonk EC; Piersma AH
    Toxicol Lett; 2014 Mar; 225(3):342-9. PubMed ID: 24480513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
    Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
    Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response.
    Robinson JF; Verhoef A; Pennings JL; Pronk TE; Piersma AH
    Toxicol Sci; 2012 Mar; 126(1):242-54. PubMed ID: 22262565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.